The European Commission has conditionally approved the marketing application submitted by Ipsen for Iqirvo (elafibranor) 80mg ...

Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary cholangitis (PBC), a rare liver diseaseApproval follows posit ...

European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for ...

A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...

Erythropoietin (EPO), expressed in red blood progenitor cells, primarily regulates erythropoiesis by binding to its receptor. Besides anemia, recent studies have identified new therapeutic indications ...

2020年9月，上海市第十人民医院在Oncology Research（IF1.9999/四区）上在线发表题为“Tripartite Motif-Containing 46 Promotes Viability and ...

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects. Peroxisome proliferator-activated receptors (PPARs) are pivotal regulators ...

艾萨克曼等四人10日乘“龙”飞船进入太空，最高抵达距地球约1400公里的高度，执行代号“北极星黎明”的航天任务。飞船后来降轨至距地面大概700公里高度，四位“观光客”将在这一高度开展太空行走任务，而国际空间站轨道高度距离地球约400公里。

New drugs approved for prurigo nodularis, burn injuries, plaque psoriasis, and more. Nemluvio (nemolizumab-ilto) Interleukin-31 receptor antagonist Treatment of adults with prurigo nodularis. Nemluvio ...

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects. Peroxisome ...